Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes (scientific article published on June 2016)

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

Q26850196

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Q26864648

Population risk prediction models for incident heart failure: a systematic review

Q26998497

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

Q29547691

Multi-Ethnic Study of Atherosclerosis: objectives and design

Q29615490

Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study

Q34397304

Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation

Q34421298

Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vasc

Q34510750

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond

Q34615977

Predictors of incident heart failure in a large insured population: a one million person-year follow-up study

Q35040761

The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening

Q35142309

Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study

Q36143273

Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum

Q36167458

Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis

Q36388330

Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community

Q36489384

Left bundle branch block as a risk factor for progression to heart failure

Q36557107

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

Q36574151

Quantifying discrimination of Framingham risk functions with different survival C statistics

Q36851295

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction

Q36993734

Relation between modifiable lifestyle factors and lifetime risk of heart failure

Q37343164

Incident heart failure prediction in the elderly: the health ABC heart failure score

Q37356725

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute

Q37417065

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association

Q37538031

The progression of hypertensive heart disease

Q37832070

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial

Q38448978

A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study

Q39743379

Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Int

Q40106164

Clinical epidemiology of heart failure: public and private health burden

Q40829008

Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study

Q40922167

PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression

Q41603258

Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study

Q43942834

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

Q45178052

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

Q46837803

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

Q46874074

N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study

Q47894878

Applying Cox Regression to Competing Risks

Q52339900

Lifetime Risk for Developing Congestive Heart Failure

Q57073232

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Q57413870

An investigation of coronary heart disease in families. The Framingham offspring study

Q59461737

Clinical Risk Stratification Optimizes Value of Biomarkers to Predict New-Onset Heart Failure in a Community-Based Cohort

Q61964929

Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy

Q68410912

An approach to longitudinal studies in a community: the Framingham Study

Q76476576

Profile for estimating risk of heart failure

???

issue

main subject

heart failure

ejection fraction

collaboration

publication date

2016-06-01

P1433

published in

Circulation: Heart Failure

Q2865806

P1476

title

Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes

P478

volume

Reverse relations

cites work (P2860)

Q92093301	Active Tobacco Smoking Impairs Cardiac Systolic Function
Q38764956	Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine
Q47739211	Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
Q61703400	Biomarkers to identify and prevent new-onset heart failure in the community
Q95938141	Clinical Course after a First Episode of Heart Failure: Insights from the Framingham Heart Study
Q90259014	Clinical significance of nutritional status in patients with chronic heart failure-a systematic review
Q64226786	Common risk factors for heart failure and cancer
Q89051114	Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction
Q50101993	Coronary Microvascular Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction
Q98161478	Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis
Q55234621	Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial.
Q96131840	Epidemiology of heart failure
Q30234501	Epidemiology of heart failure with preserved ejection fraction
Q90022466	Figures of the Heart Failure Association (HFA): Dr. Rudolf de Boer, HFA Board Member (2014-2020), Chair of the Basic Science Section (2016-2018), coordinator of the Study Group on Heart Failure with Preserved Ejection Fraction, and member of the HFA
Q64890054	Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology.
Q102371694	Heart failure development in obesity: underlying risk factors and mechanistic pathways
Q47107167	Heart failure following STEMI: a contemporary cohort study of incidence and prognostic factors
Q40081533	Heart failure with reduced ejection fraction
Q90059150	How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Q49367785	Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report
Q92424356	Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
Q52586010	Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
Q89807077	Obesity Is Associated With Pulmonary Hypertension and Modifies Outcomes
Q63871526	Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community
Q33885952	Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction
Q38606050	Poor acute outcome in congestive heart failure is associated with increases in the plasma static oxidation-reduction potentials (sORP) in men but not in women
Q50048467	Predicting heart failure: one size does not fit all.
Q46178786	Predictors and outcomes of heart failure with mid-range ejection fraction
Q104137161	Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction
Q93271952	Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
Q100995526	Prognostic value of D-dimer in acute myocardial infarction complicated by heart failure with preserved ejection fraction
Q38787755	Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction
Q47843525	Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis
Q63811744	Relation Between Cigarette Smoking and Heart Failure (from the Multiethnic Study of Atherosclerosis)
Q90600765	Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort
Q30234586	Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study
Q49911734	Sex and Race Differences in Lifetime Risk of Heart Failure with Preserved Ejection Fraction and Heart Failure with Reduced Ejection Fraction.
Q64077810	Sex differences in left ventricular afterload and diastolic function are independent from the aortic size
Q90706189	Sex-related differences in contemporary biomarkers for heart failure: a review
Q57172990	The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
Q90071196	The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure

P356	DOI	10.1161/CIRCHEARTFAILURE.115.003116
P932	PMC publication ID	4902276
P698	PubMed publication ID	27266854